[1] |
Li WQ, Qureshi AA, Schernhammer ES, et al. Rotating night⁃shift work and risk of psoriasis in US women[J]. J Invest Dermatol, 2013,133(2):565⁃567. doi: 10.1038/jid.2012.285.
|
[2] |
Feng X, Qiu W, Cheng M, et al. Association of shift work with cardiovascular disease risk among Chinese workers[J]. Chronobiol Int, 2021,38(8):1186⁃1194. doi: 10.1080/07420528.2021.191 7593.
|
[3] |
Wegrzyn LR, Tamimi RM, Rosner BA, et al. Rotating night⁃shift work and the risk of breast cancer in the Nurses′ Health Studies[J]. Am J Epidemiol, 2017,186(5):532⁃540. doi: 10.1093/aje/kwx140.
|
[4] |
Aiello I, Mul Fedele ML, Román FR, et al. Circadian disruption induced by tumor development in a murine model of melanoma[J]. Chronobiol Int, 2022,39(1):12⁃25. doi: 10.1080/07420528. 2021.1964519.
|
[5] |
Gamaleia NF, Skivka LM, Fedorchuk AG, et al. Circadian rhythms of cytotoxic activity in peripheral blood mononuclear cells of patients with malignant melanoma[J]. Exp Oncol, 2006,28(1):54⁃60.
|
[6] |
Yousef E, Mitwally N, Noufal N, et al. Shift work and risk of skin cancer: a systematic review and meta⁃analysis[J]. Sci Rep, 2020,10(1):2012. doi: 10.1038/s41598⁃020⁃59035⁃x.
|
[7] |
de Assis L, Moraes MN, Castrucci A. The molecular clock in the skin, its functionality, and how it is disrupted in cutaneous melanoma: a new pharmacological target?[J]. Cell Mol Life Sci, 2019,76(19):3801⁃3826. doi: 10.1007/s00018⁃019⁃03183⁃5.
|
[8] |
Sancar A, Van Gelder RN. Clocks, cancer, and chronochemotherapy[J]. Science, 2021,371(6524):eabb0738. doi: 10.1126/science.abb0738.
|
[9] |
de Assis L, Kinker GS, Moraes MN, et al. Expression of the circadian clock gene BMAL1 positively correlates with antitumor immunity and patient survival in metastatic melanoma[J]. Front Oncol, 2018,8:185. doi: 10.3389/fonc.2018.00185.
|
[10] |
Li M, Chen Z, Jiang T, et al. Circadian rhythm⁃associated clinical relevance and tumor microenvironment of non⁃small cell lung cancer[J]. J Cancer, 2021,12(9):2582⁃2597. doi: 10.7150/jca.52454.
|
[11] |
Aiello I, Fedele M, Román F, et al. Circadian disruption promotes tumor⁃immune microenvironment remodeling favoring tumor cell proliferation[J]. Sci Adv, 2020,6(42):eaaz4530. doi: 10.1126/sciadv.aaz4530.
|
[12] |
Zhang M, He Y, Sun X, et al. A high M1/M2 ratio of tumor⁃associated macrophages is associated with extended survival in ovarian cancer patients[J]. J Ovarian Res, 2014,7:19. doi: 10.1186/1757⁃2215⁃7⁃19.
|
[13] |
Alexander RK, Liou YH, Knudsen NH, et al. Bmal1 integrates mitochondrial metabolism and macrophage activation[J]. Elife, 2020,9:e54090. doi: 10.7554/eLife.54090.
|
[14] |
Sarkar S, Gaddameedhi S. Solar ultraviolet⁃induced DNA damage response: melanocytes story in transformation to environmental melanomagenesis[J]. Environ Mol Mutagen, 2020,61(7):736⁃751. doi: 10.1002/em.22370.
|
[15] |
Sample A, He YY. Mechanisms and prevention of UV⁃induced melanoma[J]. Photodermatol Photoimmunol Photomed, 2018,34(1):13⁃24. doi: 10.1111/phpp.12329.
|
[16] |
Schuch AP, Moreno NC, Schuch NJ, et al. Sunlight damage to cellular DNA: focus on oxidatively generated lesions[J]. Free Radic Biol Med, 2017,107:110⁃124. doi: 10.1016/j.freeradbiomed. 2017.01.029.
|
[17] |
Gaddameedhi S, Selby CP, Kemp MG, et al. The circadian clock controls sunburn apoptosis and erythema in mouse skin[J]. J Invest Dermatol, 2015,135(4):1119⁃1127. doi: 10.1038/jid.2014. 508.
|
[18] |
Kang TH, Leem SH. Modulation of ATR⁃mediated DNA damage checkpoint response by cryptochrome 1[J]. Nucleic Acids Res, 2014,42(7):4427⁃4434. doi: 10.1093/nar/gku094.
|
[19] |
Sarkar S, Porter KI, Dakup PP, et al. Circadian clock protein BMAL1 regulates melanogenesis through MITF in melanoma cells[J]. Pigment Cell Melanoma Res, 2021,34(5):955⁃965. doi: 10.1111/pcmr.12998.
|
[20] |
Liyanage UE, MacGregor S, Bishop DT, et al. Multi⁃trait genetic analysis identifies autoimmune loci associated with cutaneous melanoma[J/OL]. J Invest Dermatol, 2021:S0022⁃202X(21)02513⁃6[2022⁃03⁃15]. doi: 10.1016/j.jid.2021.08.449.
|
[21] |
Benna C, Rajendran S, Spiro G, et al. Gender⁃specific associations between polymorphisms of the circadian gene RORA and cutaneous melanoma susceptibility[J]. J Transl Med, 2021,19(1):57. doi: 10.1186/s12967⁃021⁃02725⁃5.
|
[22] |
Franzoni A, Markova⁃Car E, Dević⁃Pavlić S, et al. A polymorphic GGC repeat in the NPAS2 gene and its association with melanoma[J]. Exp Biol Med (Maywood), 2017,242(15):1553⁃1558. doi: 10.1177/1535370217724093.
|
[23] |
Lee Y, Fong SY, Shon J, et al. Time⁃of⁃day specificity of anticancer drugs may be mediated by circadian regulation of the cell cycle[J]. Sci Adv, 2021,7(7):eabd2645. doi: 10.1126/sciadv.abd2645.
|
[24] |
Wagner PM, Prucca CG, Velazquez FN, et al. Temporal regulation of tumor growth in nocturnal mammals: in vivo studies and chemotherapeutical potential[J]. FASEB J, 2021,35(2):e21231. doi: 10.1096/fj.202001753R.
|
[25] |
Kiessling S, Beaulieu⁃Laroche L, Blum ID, et al. Enhancing circadian clock function in cancer cells inhibits tumor growth[J]. BMC Biol, 2017,15(1):13. doi: 10.1186/s12915⁃017⁃0349⁃7.
|
[26] |
Zhang R, Zheng S, Guo Z, et al. L⁃theanine inhibits melanoma cell growth and migration via regulating expression of the clock gene BMAL1[J]. Eur J Nutr, 2022,61(2):763⁃777. doi: 10. 1007/s00394⁃021⁃02677⁃y.
|